First Hospital of Jiaxing
In research, First Hospital of Jiaxing stands highest in Medicine (#1,705 of 10,443 worldwide), Health Sciences (#1,969 of 11,982 worldwide) and Life Sciences (#2,314 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Cancer Research — Cancer Research is 8.0× its share of world research.
- World rank, 2022–2025
- #4,536 of 28,054 · #10,173 all time
- Rank in China
- #1,025 of 3,058
- Research works
- 2.3k ▲ 13% vs 2013–17
- Citations
- 12k 5.4 per fractional work
- Top-10% rate
- 17.9% record average 16.5%
- Open access
- 45% world 28%
What is First Hospital of Jiaxing known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #1,705 of 10,443 | 17.0% | 466 | #3964 | |
| Health SciencesDomain | #1,969 of 11,982 | 17.0% | 487 | #4494 | |
| Life SciencesDomain | #2,314 of 7,800 | 19.8% | 197 | #5273 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,213 of 3,579 | 19.3% | 129 | #5133 | |
| SurgerySubfield | #1,273 of 1,816 | 15.3% | 66 | #2858 | |
| Molecular BiologySubfield | #1,792 of 2,175 | 18.6% | 73 | #3892 |
Each strip is that field’s whole ranked pool, with the notch where First Hospital of Jiaxing sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#3,964 #1,705
- Health Sciences#4,494 #1,969
- Life Sciences#5,273 #2,314
- Biochemistry, Genetics and Molecular Biology#5,133 #2,213
- Surgery#2,858 #1,273
- Molecular Biology#3,892 #1,792
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does First Hospital of Jiaxing specialise in?
Where its research is concentrated relative to its size: Cancer Research takes 8.0× the share of its output that it takes of world research.
- Cancer ResearchSubfield · 26.0 works8.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.8×. Every wedge is a field page.
- Immunology and Microbiology 3.8×
- Medicine 3.2×
- Biochemistry, Genetics and Molecular Biology 3.2×
- Neuroscience 2.2×
- Pharmacology, Toxicology and Pharmaceutics 2.0×
- Nursing 1.5×
- Dentistry 1.1×
- Veterinary 0.7×
- Health Professions 0.6×
- Chemistry 0.5×
- Psychology 0.3×
- Environmental Science 0.3×
- Materials Science 0.2×
- Agricultural and Biological Sciences 0.2×
- Engineering 0.2×
- Computer Science 0.1×
- Energy 0.1×
- Mathematics 0.1×
- Decision Sciences 0.1×
- Economics, Econometrics and Finance 0.1×
- Chemical Engineering 0.0×
- Earth and Planetary Sciences 0.0×
- Physics and Astronomy 0.0×
- Social Sciences 0.0×
- Arts and Humanities 0.0×
Who are the top researchers at First Hospital of Jiaxing?
Ranked on the composite score, Hua Wu, Xudong Gu and Bing Huang lead among researchers whose main affiliation is First Hospital of Jiaxing.
- 1 Hua Wu China · #476,284 worldwide 66 citations · 21 works
- 2 Xudong Gu China · #672,847 worldwide 45 citations · 25 works
- 3 Bing Huang China · #1,483,853 worldwide 0 citations · 16 works
- 4 Zhengxiang Zhong China · #1,545,660 worldwide 15 citations · 15 works
Which keywords describe research at First Hospital of Jiaxing?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Oxidative Stress, Epidemiology, Tumor Microenvironment, Metastasis, Treatment and Gene Expression.
- Elderly Patients
- Hepatocellular Carcinoma
- Cancer Progression
- Thrombosis
- Ferroptosis
- Rehabilitation
- Neuroinflammation
- Biogenesis
- Regulation
- Clinical Trials
- Immunity
- Metabolic Syndrome
- Cell Death
- Chemotherapy
- Clinical Practice Guidelines
- Quality of Life
- Gene Expression
- Treatment
- Oxidative Stress
- Epidemiology
- Inflammation
- Cancer
- Tumor Microenvironment
- Diagnosis
- Metastasis
- Biomarkers
- Cardiovascular Disease
- Management
- Immunotherapy
- Risk Factors
- Immune Response
- Prognostic Factors
- Guidelines
- Pain Management
- Neuroprotection
- Lipid Peroxidation
- GPX4
- Chronic Pain
- Epigenetic Regulation
- Perioperative Care
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation74▲ 4.8×77 topics
- Epidemiology66▲ 2.2×103 topics
- Cancer66▲ 6.6×49 topics
- Oxidative Stress50▲ 4.1×52 topics
- Tumor Microenvironment36▲ 11×8 topics
- Treatment34▲ 3.7×43 topics
- Diagnosis29▲ 4.2×33 topics
- Gene Expression26▲ 5.8×15 topics
- Metastasis24▲ 9.6×12 topics
- Quality of Life23▲ 2.1×40 topics
- Biomarkers23▲ 4.5×14 topics
- Clinical Practice Guidelines23▲ 5.6×14 topics
- Cardiovascular Disease22▲ 2.7×32 topics
- Chemotherapy22▲ 4.3×19 topics
- Management22▲ 3.8×23 topics
- Cell Death22▲ 12×6 topics
- Immunotherapy20▲ 3.8×18 topics
- Metabolic Syndrome20▲ 3.3×20 topics
- Risk Factors19▲ 2.3×24 topics
- Immunity19▲ 6.3×9 topics
- Immune Response19▲ 4.4×19 topics
- Clinical Trials16▲ 3.2×14 topics
- Prognostic Factors15▲ 4.7×14 topics
- Regulation15▲ 3.8×10 topics
- Guidelines15▲ 4.4×12 topics
- Biogenesis14▲ 10×3 topics
- Pain Management13▲ 7.8×7 topics
- Neuroinflammation13▲ 6.2×6 topics
- Neuroprotection13▲ 5.0×15 topics
- Rehabilitation13▲ 4.4×11 topics
- Lipid Peroxidation13▲ 16×3 topics
- Ferroptosis12▲ 22×1 topic
- GPX412▲ 22×1 topic
- Thrombosis12▲ 5.7×7 topics
- Chronic Pain12▲ 7.2×5 topics
- Cancer Progression12▲ 8.5×8 topics
- Epigenetic Regulation11▲ 6.8×5 topics
- Hepatocellular Carcinoma11▲ 7.0×3 topics
- Perioperative Care10▲ 12×3 topics
- Elderly Patients10▲ 8.2×4 topics
Which research topics does First Hospital of Jiaxing publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Cancer-related molecular mechanisms research, Cancer Immunotherapy and Biomarkers and RNA modifications and cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 12 works
- 2 Cancer-related molecular mechanisms research Cancer Research 8 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 7 works
- 4 RNA modifications and cancer Molecular Biology 7 works
- 5 Anesthesia and Pain Management Surgery 6 works
- 6 MicroRNA in disease regulation Cancer Research 6 works
- 7 Inflammatory Biomarkers in Disease Prognosis Oncology 6 works
- 8 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 6 works
- 9 Intensive Care Unit Cognitive Disorders Critical Care and Intensive Care Medicine 5 works
- 10 Circular RNAs in diseases Molecular Biology 5 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has First Hospital of Jiaxing's research output changed?
Output in 2018–2022 was 13% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Jiaxing
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.